Henry Pertinez
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Tuberculosis Research and Epidemiology 13
- SARS-CoV-2 and COVID-19 Research 4
- SARS-CoV-2 detection and testing 3
- HIV/AIDS drug development and treatment 2
-
- Mycobacterium research and diagnosis 3
- Co-authors
- Geraint Davies (11 shared papers)Leon Aarons (2 shared papers)Charles A. Peloquin (3 shared papers)Kayode Ogungbenro (1 shared paper)Yingjun Liu (4 shared papers)Anthony Coates (4 shared papers)Yanmin Hu (4 shared papers)Saye Khoo (5 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)Antimicrobial Agents and Chemotherapy (5 papers)British Journal of Clinical Pharmacology (3 papers)Pharmaceutics (2 papers)Clinical Infectious Diseases (2 papers)
- Partner nations
- United KingdomUnited StatesMalawi
In The Last Decade
Henry Pertinez
26 papers receiving 518 citations
Peers
Comparison fields: 5 of 81
- Infectious Diseases 232
- Pharmacology 92
- Pharmaceutical Science 41
- Pharmacology 64
- Molecular Medicine 18
Countries citing papers authored by Henry Pertinez
This map shows the geographic impact of Henry Pertinez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Pertinez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Pertinez more than expected).
Fields of papers citing papers by Henry Pertinez
This network shows the impact of papers produced by Henry Pertinez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Pertinez. The network helps show where Henry Pertinez may publish in the future.
Co-authors
The 25 scholars most cited alongside Henry Pertinez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 85 | |
| 2 | 2018 | 78 | |
| 3 | 2018 | 72 | |
| 4 | 2018 | 28 | |
| 5 | 2014 | 27 | |
| 6 | 2015 | 22 | |
| 7 | 2019 | 21 | |
| 8 | 2012 | 18 | |
| 9 | 2017 | 18 | |
| 10 | 2021 | 18 | |
| 11 | 2016 | 17 | |
| 12 | 2021 | 16 | |
| 13 | 2017 | 16 | |
| 14 | 2020 | 14 | |
| 15 | 2017 | 13 | |
| 16 | 2013 | 12 | |
| 17 | 2009 | 11 | |
| 18 | 2020 | 10 | |
| 19 | 2023 | 6 | |
| 20 | 2022 | 5 |
About Henry Pertinez
Henry Pertinez is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Virology and Rheumatology, having authored 31 papers that have together received 525 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (13 papers), SARS-CoV-2 and COVID-19 Research (4 papers), SARS-CoV-2 detection and testing (3 papers), Mycobacterium research and diagnosis (3 papers), HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (2 papers), Hepatitis C virus research (2 papers) and Systemic Lupus Erythematosus Research (2 papers). The work is most often cited by research in Infectious Diseases (232 citations), Pharmacology (92 citations), Pharmaceutical Science (41 citations), Pharmacology (64 citations) and Molecular Medicine (18 citations). Henry Pertinez has collaborated with scholars based in United Kingdom, United States and Malawi. Frequent co-authors include Geraint Davies, Leon Aarons, Charles A. Peloquin, Kayode Ogungbenro, Yingjun Liu, Anthony Coates, Yanmin Hu, Saye Khoo, Andrew Owen and Jan‐Willem C. Alffenaar. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, British Journal of Clinical Pharmacology, Pharmaceutics and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.